Nicollet Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-10,923
Closed -$3.1M 63
2020
Q3
$3.1M Buy
10,923
+145
+1% +$40.4K 1.57% 22
2020
Q2
$2.88M Sell
10,778
-28
-0.3% -$8.42K 1.61% 22
2020
Q1
$3.42M Sell
10,806
-360
-3% -$109K 2.53% 9
2019
Q4
$3.31K Buy
11,166
+5,181
+87% +$1.44M 1.55% 17
2019
Q3
$1.39M Sell
5,985
-370
-6% -$86.2K 0.88% 36
2019
Q2
$1.49M Sell
6,355
-175
-3% -$40.4K 0.93% 36
2019
Q1
$1.54M Buy
6,530
+250
+4% +$78.7K 1.02% 33
2018
Q4
$1.89M Buy
6,280
+535
+9% +$171K 1.49% 25
2018
Q3
$2.03M Hold
5,745
1.32% 27
2018
Q2
$1.67M Sell
5,745
-85
-1% -$23.9K 1.2% 30
2018
Q1
$1.6M Sell
5,830
-145
-2% -$45K 1.24% 29
2017
Q4
$1.9M Buy
+5,975
New +$1.92M 1.56% 20

Other funds holding BIIB

Nicollet Investment Management's BIIB Position: Q4 2020 in Review

Nicollet Investment Management sold out of Biogen (BIIB) in Q4 2020, closing a stake of 10,923 shares — an estimated $3.1M sold.

Nicollet Investment Management first reported a position in BIIB in Q4 2017 and held it in 12 quarters. The position peaked at $3.42M in Q1 2020. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Nicollet Investment Management reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Nicollet Investment Management sold 10,923 Biogen shares in Q4 2020, an estimated $3.1M.
  • Nicollet Investment Management first reported a position in Biogen in Q4 2017 and held it in 12 quarters.
  • Nicollet Investment Management's Biogen position peaked at $3.42M in Q1 2020.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Nicollet Investment Management's 13F filing for Q4 2020, filed 9 Feb 2021.